| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Innoviva, Inc. | 10%+ Owner | $163M | Jul 8, 2022 | ||
| Michael Gutch | Chief Financial Officer and Chief Business Officer | Jan 18, 2022 | |||
| David C. Hastings | Director | Jul 7, 2022 | |||
| Anna Diaz Triola | Chief Commercial Officer | Jul 11, 2022 | |||
| Matthew Ronsheim | Chief of Pharma Sciences & MFG | Jul 7, 2022 | |||
| Ruben Tommasi | Chief Scientific Officer | Jul 7, 2022 | |||
| Manoussos Perros | President and CEO, Director | Jul 7, 2022 | |||
| Heather A. Berger | Director | Jul 7, 2022 | |||
| Kristie Wagner | VP, Principal Fin & Acct Off | Jul 11, 2022 | |||
| David D. Meek | Director | Jul 7, 2022 | |||
| Elizabeth M. Keiley | General Counsel | Jul 7, 2022 | |||
| Howard Mayer | Director | Jul 7, 2022 | |||
| David Altarac | Chief Medical Officer | Jul 7, 2022 | |||
| John Patrick Mueller | Chief Development Officer | Jul 7, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|